Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China
Clinical trial NCT05682599 · UNKNOWN
Trial details
- NCT number
- NCT05682599
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-06
- Primary completion
- 2023-04-15
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.